TriangleHEALTH PROFESSIONAL · SOURCE READING
Ependymal Tumors Treatment
Source: Central Nervous System Tumors Treatment (PDQ®)–Health Professional Version, National Cancer Institute.
Source updated: March 28, 2025 · Captured 2026-09-09.
Selected source text with whitespace normalised. This Triangle page is not an NCI PDQ summary.
Context: Treatment of Primary CNS Tumors by Tumor Type
Ependymal tumors (WHO grade I) and ependymomas (WHO grade II)—i.e., subependymomas and myxopapillary ependymomas—are often curable.
Treatment options for grades I and II ependymal tumors include:
Surgery alone if the tumor is totally resectable.
Surgery followed by radiation therapy to known or suspected residual tumor.
Patients with anaplastic ependymomas (WHO grade III) have variable prognoses that depend on the location and extent of disease. Frequently, but not invariably, patients with anaplastic ependymomas have worse prognoses than do those patients with lower-grade ependymal tumors.
Treatment options for anaplastic ependymomas include:
Surgery plus radiation therapy.[30]
Source links and citations
Publication references
Read the original reference and check its publication notices.
Preserved source evidence · Not medical advice